Jonathan Keats, PhD 🇨🇦
banner
pedalheadphx.bsky.social
Jonathan Keats, PhD 🇨🇦
@pedalheadphx.bsky.social
🇨🇦 boiling in the Arizona desert and not riding my bikes enough. Cancer researcher focused on multiple myeloma and clinical genomics at TGen, part of City of Hope. Creator of MyelomaSky and Sequencing Tech feeds. Director, Collaborative Sequencing Center
Pinned
go.bsky.app/BtBs6xj Still slowly building a myeloma research oriented starter pack, let me know if you are missing.
Very important work from a great Canadian team. Building an important part of how we will monitor myeloma patients in the future and maybe define a cure
Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple Myeloma https://www.medrxiv.org/content/10.1101/2025.10.24.25338566v1
October 28, 2025 at 3:57 AM
Reposted by Jonathan Keats, PhD 🇨🇦
Common diseases can be misdiagnosed as actually being due to rare, disease-causing genome variants. DNA and RNA sequencing can make the true diagnosis, which affects response to therapy @nejm.org
www.nejm.org/doi/full/10....
October 22, 2025 at 9:17 PM
Reposted by Jonathan Keats, PhD 🇨🇦
Transcriptional interferences ensure one olfactory receptor per ant neuron
www.nature.com/articles/s41...

Caviar for RNA-Seq nerds! Check this out
October 22, 2025 at 8:40 PM
@cityofhope.bsky.social multiple myeloma leader Dr. Amrita Krishnan is now the SWOG multiple myeloma chair.
October 21, 2025 at 4:14 PM
Way to go Blue Jays
October 21, 2025 at 3:15 AM
Reposted by Jonathan Keats, PhD 🇨🇦
Vaccines are safe and effective.

Autism isn't caused by vaccines, and autistic people and their families deserve our support.

When you want information, ask your doctor.

It's more important than ever for all of us to speak plainly, truthfully, and directly about public health.
October 14, 2025 at 1:33 AM
@sci-bri.bsky.social moving from 2 weeks of sunshine to a year of it, great line
October 14, 2025 at 12:16 AM
Reposted by Jonathan Keats, PhD 🇨🇦
Bridging therapy with #talquetamab enabled patients with high-risk #myeloma #MMsm to successfully transition to #BCMA #CARTcell therapy, with 88% experiencing rapid disease control and proceeding to treatment with ide-cel or cilta-cel: ow.ly/7JkM50X8KYa
#HemeSky #MyelomaSky #MultipleMyeloma
Talquetamab Bridging Therapy Enables Transition to BCMA CAR-T for Patients With High-Risk Myeloma | ASH Clinical News | American Society of Hematology
ow.ly
October 9, 2025 at 5:34 PM
Reposted by Jonathan Keats, PhD 🇨🇦
What an amazing assay.

DAF-seq, the evolution of Fiber-seq from the Andrew Stergachis group, using the @pacbio.bsky.social platform:
www.biorxiv.org/content/10.1...

This will revolutionise our understanding of transcriptional regulation and functional non-coding variants.
Deaminase-assisted single-molecule and single-cell chromatin fiber sequencing
Gene regulation is mediated by the co-occupancy of numerous proteins along individual chromatin fibers. However, our tools for deeply profiling how proteins co-occupy individual fibers, especially at ...
www.biorxiv.org
October 4, 2025 at 12:06 PM
How old is this plane, don’t remember the last time I saw volume and channel controls in the arm rest
October 7, 2025 at 3:04 PM
Interesting work on genes that regulate anti-BCMA CAR-T efficacy in myeloma.
September 28, 2025 at 8:03 PM
Awesome to see a 🇨🇦 in the rainbow jersey
'I saw she was fading a little bit, so I told myself I just had to go all in now and try something...'

How the first-ever Canadian rainbow jersey in the elite UCI road world championships was won

https://bit.ly/4nmaaJH
‘It Is Crazy’: Magdeleine Vallieres Reflects on Shock World Championships Win
Alison Jackson celebrates success of teammate Vallieres, with her own Paris-Roubaix victory a likely catalyst.
velo.outsideonline.com
September 28, 2025 at 12:16 AM
Reposted by Jonathan Keats, PhD 🇨🇦
I am excited to share my first work in @schapirolab.bsky.social on Multiple Myeloma (MM) in collaboration with the Standal Lab from NTNU Norway. We use Imaging Mass Cytometry (IMC) on bone marrow biopsies from MM and precursor patients (details below): www.biorxiv.org/content/10.1...
Highly multiplexed imaging recovers immune and metabolic niches in multiple myeloma associated with disease progression and bone involvement
Multiple myeloma (MM) is a cancer arising from genetically aberrant plasma cells (PCs) that remain dependent on the bone marrow (BM) microenvironment for disease establishment and progression. Here, w...
www.biorxiv.org
September 13, 2025 at 8:25 AM
Reposted by Jonathan Keats, PhD 🇨🇦
🚨 Our parent-of-origin study is out in Nature! 🧬
Maternal and paternal alleles can have distinct — even opposite — effects on human traits, revealing a hidden layer of genetic architecture that standard GWAS miss.
🔗 www.nature.com/articles/s41...

Highlights below!
August 6, 2025 at 6:27 PM
Interesting @nebanovich.bsky.social @florisbarthel.bsky.social glad we just installed an @elembio.bsky.social Aviti24 @tgenresearch.bsky.social. @aphillippy.bsky.social is this with standard cloudbreak chemistry or the high accuracy ultraQ chemistry
Definitely hard to measure, but here is our best attempt from a new benchmarking paper to be preprinted in the next few weeks. Element appears to be the current king of homopolymers. Illumina does worse than HiFi beyond 20 bp. (This is all measured on human DNA)
September 6, 2025 at 7:15 PM
Reposted by Jonathan Keats, PhD 🇨🇦
September 4, 2025 at 12:07 AM
Reposted by Jonathan Keats, PhD 🇨🇦
The latest human GENCODE releases for Human (49) and Mouse (M38), have just been released. They're available via gencodegenes.org and visible in @ensembl genome browser as part of Ensembl 115 ensembl.org
GENCODE - Home page
gencodegenes.org
September 3, 2025 at 11:16 AM
Asking for a friend, to my pathology colleagues, please ensure ISCN sections are on your FISH reports
September 3, 2025 at 12:29 AM
Reposted by Jonathan Keats, PhD 🇨🇦
Thank you Tommy!
The link you gave is good but points to a 2yr old rendering. This one uses recent versions of R and all packages and has all the latest typo fixes:
www.huber.embl.de/msmb/
Modern Statistics for Modern Biology
If you are a biologist and want to get the best out of the powerful methods of modern computational statistics, this is your book.
www.huber.embl.de
August 29, 2025 at 1:48 PM
Reposted by Jonathan Keats, PhD 🇨🇦
Pleased to say that our preprint benchmarking Nanopore data for MLST, cgMLST, cgSNP & AMR typing from bacterial isolates is out! TL;DR you can get almost perfect results from 50x depth using live SUP basecalling with a GPU in under 20 hours #microsky#IDsky 🦠🧬🖥️ /1
www.medrxiv.org/content/10.1...
July 30, 2025 at 2:11 AM
Reposted by Jonathan Keats, PhD 🇨🇦
New prognostic systems for multiple myeloma in the context of contemporary therapies url: ashpublications.org/blood/articl...
New prognostic systems for multiple myeloma in the context of contemporary therapies
Recent clinical trials in both transplant eligible and ineligible newly diagnosed multiple myeloma utilising three and four drug combinations have demonstr
ashpublications.org
July 31, 2025 at 1:50 PM
Sarcastic me: Ah I feel so bad for him… Honest me: please don’t give this piece of shit a platform, hope no one hires him as it just helps is platform of spewing crap appear academic in origin
statnews.com STAT @statnews.com · Jul 30
#Breaking: Vinay Prasad, a top official at the Food and Drug Administration, has suddenly departed after a series of controversial decisions about a treatment for boys with Duchenne muscular dystrophy.
www.statnews.com/2025/07/29/v...
Vinay Prasad departs the FDA
A top FDA official is out after less than 3 months on the job.
www.statnews.com
July 30, 2025 at 1:21 AM
This is yet another amazing outcome of large public datasets like the UK bio bank. Suspect having a high serum BAFF level means you don’t have many plasma cells, wonder if those people have frequent infections
Dysregulated immune proteins in plasma in the UK Biobank predict multiple myeloma 12 years before clinical diagnosis, regardless of MGUS status, amazing work!: ashpublications.org/bloodadvance...
Dysregulated immune proteins in plasma in the UK Biobank predict multiple myeloma 12 years before clinical diagnosis
TO THE EDITOR:
ashpublications.org
July 28, 2025 at 10:35 PM
Reposted by Jonathan Keats, PhD 🇨🇦
Dysregulated immune proteins in plasma in the UK Biobank predict multiple myeloma 12 years before clinical diagnosis, regardless of MGUS status, amazing work!: ashpublications.org/bloodadvance...
Dysregulated immune proteins in plasma in the UK Biobank predict multiple myeloma 12 years before clinical diagnosis
TO THE EDITOR:
ashpublications.org
July 27, 2025 at 5:08 PM
Reposted by Jonathan Keats, PhD 🇨🇦
Sauber only had two bottles of champagne, both Mercedes and Aston Martin sent them all of theirs so the team could celebrate properly!

A very hard fought well deserved podium for both team and driver
#BritishGP
July 6, 2025 at 6:38 PM